Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury

European Respiratory Journal

Volumn 47, Issue 4, 2016, Pages 1219-1228

  Roquilly, Antoine ^a   Feuillet, Fanny ^b,c   Seguin, Philippe ^d   Lasocki, Sigismond ^e   Cinotti, Raphael ^a   Launey, Yoann ^d   Thioliere, Lise ^e   Le Floch, Ronan ^a   Joachim Mahe, Pierre ^a   Nesseler, Nicolas ^d   Cazaubiel, Tanguy ^a   Rozec, Bertrand ^f   Lepelletier, Didier ^a   Sebille, Véronique ^b,c   Malledant, Yannick ^d   Asehnoune, Karim ^a  

^a HÔTEL DIEU   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Universite de Nantes   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFTRIAXONE; LEVOFLOXACIN; SULTAMICILLIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BRAIN INJURY; BURN; CEREBROVASCULAR ACCIDENT; DRUG TREATMENT FAILURE; EXTERNAL VALIDITY; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY; VENTILATOR ASSOCIATED PNEUMONIA; AREA UNDER THE CURVE; BRAIN INJURIES; BURNS; CLINICAL TRIAL; COMPLICATION; GLASGOW COMA SCALE; INCIDENCE; INTENSIVE CARE UNIT; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PNEUMONIA, VENTILATOR-ASSOCIATED; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BRAIN INJURIES; BURNS; DRUG RESISTANCE, BACTERIAL; FEMALE; GLASGOW COMA SCALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA, VENTILATOR-ASSOCIATED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84964054454     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01314-2015     Document Type: Article

References (33)

1. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302: 2323-2329.
2. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122: 262-268.
3. Bouza E, Granda MJP, Hortal J, et al. Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients. Intensive Care Med 2013; 39: 1547-1555.
4. Fauci AS, Marston LD. The perpetual challenge of antimicrobial resistance. JAMA 2014; 311: 1853-1854.
5. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
6. Braykov NP, Morgan DJ, Schweizer ML, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis 2014; 14: 1220-1227.
7. Kett DH, Cano E, Quartin AA, et al. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011; 11: 181-189.
8. Agbaht K, Lisboa T, Pobo A, et al. Management of ventilator-associated pneumonia in a multidisciplinary intensive care unit: does trauma make a difference? Intensive Care Med 2007; 33: 1387-1395.
9. Kashuk JL, Moore EE, Price CS, et al. Patterns of early and late ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in a trauma population. J Trauma 2010; 69: 519-522.
10. Seguin P, Laviolle B, Dahyot-Fizelier C, et al. Effect of oropharyngeal povidone-iodine preventive oral care on ventilator-associated pneumonia in severely brain-injured or cerebral hemorrhage patients: A multicenter, randomized controlled trial. Crit Care Med 2014; 42: 1-8.
11. Roquilly A, Cinotti R, Jaber S, et al. Implementation of an evidence-based extubation readiness bundle in 499 brain-injured patients. A before-after evaluation of a quality improvement project. Am J Respir Crit Care Med 2013; 188: 958-966.
12. Asehnoune K, Seguin P, Allary J, et al. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): A double-blind, multicentre phase 3, randomised placebo-controlled trial. Lancet Respir Med 2014; 2: 706-716.
13. Elm von E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007; 4: e296.
14. Mosier MJ, Pham TN. American Burn Association Practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia (VAP) in burn patients. J Burn Care Res 2009; 30: 910-928.
15. Magill SS, Klompas M, Balk R, et al. Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Chest 2013; 144: 1448-1452.
16. Lambert M-L, Suetens C, Savey A, et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: A cohort study. Lancet Infect Dis 2011; 11: 30-38.
17. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128: 3854-3862.
18. Hippisley-Cox J, Coupland C. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores. BMJ 2014; 349: g4606.
19. Rello J, Sa-Borges M, Correa H, et al. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160: 608-613.
20. Carbonne A, Arnaud I, Maugat S, et al. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: A 9 year experience. J Antimicrob Chemother 2013; 68: 954-959.
21. Martin-Loeches I, Deja M, Koulenti D, et al. Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: The interaction of ecology, shock and risk factors. Intensive Care Med 2013; 39: 672-681.
22. Vallés J, Martin-Loeches I, Torres A, et al. Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: A Spanish cohort study. Intensive Care Med 2014; 40: 572-581.
23. Doi Y, Park YS, Rivera JI, et al. Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 2013; 56: 641-648.
24. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157: 531-539.
25. Liberati A, D'Amico R, Pifferi S, et al. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2009; 4: CD000022.
26. Roquilly A, Marret E, Abraham E, et al. Pneumonia prevention to decrease mortality in intensive care unit: A systematic review and meta-analysis. Clin Infect Dis 2015; 60: 64-75.
27. Kollef MH, Chastre J, Fagon J-Y, et al. Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit Care Med 2014; 42: 2178-2187.
28. Ewig S, Welte T, Chastre J, et al. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010; 10: 279-287.
29. Haverkate MR, Derde LPG, Brun-Buisson C, et al. Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Med 2014; 40: 564-571.
30. Salgado CD, O Grady N, Farr BM. Prevention and control of antimicrobial-resistant infections in intensive care patients. Crit Care Med 2005; 33: 2373-2382.
31. Chang F-Y, Peacock JE Jr, Musher DM, et al. Staphylococcus aureus bacteremia. Medicine 2003; 82: 333-339.
32. Rello J, Lipman J. Antibiotic prescription for respiratory tract infections in ventilated patients: where are we heading? Intensive Care Med 2013; 39: 1644-1646.
33. Rello J, Chastre J, Cornaglia G, et al. A European care bundle for management of ventilator-associated pneumonia. J Crit Care 2011; 26: 3-10.